Deutsch
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
esophageal and gastric varices/albumin
Der Link wird in der Zwischenablage gespeichert
15 Ergebnisse
To Study Efficacy of Albumin in Cirrhosis With Spontaneous Bacterial Peritonitis at Low Risk for AKI Development
Nur registrierte Benutzer können Artikel übersetzen
Einloggen Anmelden
1. Aim- To compare the efficacy of albumin when compared to placebo in the development or progression of AKI in patients with cirrhosis and spontaneous bacterial peritonitis who are at low risk for AKI development (i.e Serum Bilirubin <4 mg/dL and serum creatinine < 1 mg/dl at presentation)
-
EUS-guided Obturation of High Risk Gastric Varices Versus Standard Endoscopic Treatment
Nur registrierte Benutzer können Artikel übersetzen
Einloggen Anmelden
This is a single-centre, pilot randomized trial study that includes 42 patients with gastric varices that will be classified according to the Sarin and Kumar classification into GOV II or IGV I with recently bleeding GV & high-risk GV (defined by Baveno VI consensus for primary
Hepatocellular Carcinoma in HIV-infected Individuals in Asian Population
Nur registrierte Benutzer können Artikel übersetzen
Einloggen Anmelden
The incidence of hepatocellular carcinoma (HCC) is increasing over time among the HIV-infected population, and is an increasingly important cause of morbidity and mortality in HIV-infected individuals. Despite effective treatment for HBV and HCV infections, HCC is still reported in treated
Sarcopenia Improves the Muscle Mass and Muscle Strength of Patients With Liver Cirrhosis-Child C
Nur registrierte Benutzer können Artikel übersetzen
Einloggen Anmelden
Globally, the mortality after any infection in cirrhosis patients is very high. The cumulative mortality in patients with infections was 43.5% (11,987 patients) where as the mortality rate without infection was 13.6% (2317 patients). Over the years, variceal bleeding causing death in cirrhosis has
Non-invasive Methods to Predict PHG in Cirrhosis
Nur registrierte Benutzer können Artikel übersetzen
Einloggen Anmelden
Cirrhosis is the end-stage of every chronic liver disease. Histologically, cirrhosis is characterized by regenerative nodules surrounded by fibrous bands, which can be divided into compensated phase and decompensated one. Compensated phase is referred to as asymptomatic stages, also known as
Long Term Follow-up of Hepatitis C Cured Patients
Nur registrierte Benutzer können Artikel übersetzen
Einloggen Anmelden
HYPOTHESIS:
- The prognosis of cACLD patients who achieve SVR will improve during follow-up and this will be reflected in an improvement in liver and spleen stiffness and reduction of liver-related events. However, on an individual basis, because of many confounding factors, predictability is
Real World Experience of Chronic Hepatitis C (CHC) Treatment in Israel
Nur registrierte Benutzer können Artikel übersetzen
Einloggen Anmelden
The following data will be collected:
Demographics information: age, gender, race, country of birth (COB). Data on liver and virological characteristics: Hepatitis C virus(HCV) genotype, fibrosis stage (F0-4), technology of fibrosis assessment (fibroscan, fibrotest, elastography, biopsy), ,
Study of the What the Body Does to the Drug in Subjects With Mild, Moderate, and Severe Liver Dysfunction
Nur registrierte Benutzer können Artikel übersetzen
Einloggen Anmelden
This is an open-label single-dose study. Approximately 40 total subjects will be enrolled. In each of the 3 hepatic impairment groups (mild hepatic dysfunction [Child-Pugh score of 5 - 6], moderate hepatic dysfunction [Child-Pugh score of 7 - 9], severe hepatic dysfunction [Child Pugh score of 10 -
Diclophenac Versus Placebo for Pain Control in Diagnostic Colonoscopy
Nur registrierte Benutzer können Artikel übersetzen
Einloggen Anmelden
Aim:
To determine the effectiveness of oral diclophenac sodium on the quality of colonoscopy and pain control during diagnostic colonoscopy in hospitalized patients.
Hypothesis:
Null hypothesis: there is no statistically significant difference between diclophenac sodium and placebo on parameters of
Efficacy of Granulocyte Colony-stimulating Factor and Erythropoetin for Patients With Acute-on-chronic Liver Failure
Nur registrierte Benutzer können Artikel übersetzen
Einloggen Anmelden
50 patients of ACLF will be enrolled and randomized into G-CSF+EPO or Placebo arms
Baseline investigations:
- Hematology
- CBC, Prothrombin time and INR
- Peripheral smear, Retics
- Biochemistry
- Liver function testing, AFP
- Kidney function test
- Etiology of acute event:
- Infectious etiology:
B-type Natriuretic Peptide in the Diagnosis of Heart Failure Related Ascites
Nur registrierte Benutzer können Artikel übersetzen
Einloggen Anmelden
Diagnostic criteria for the cause of ascites - two independent cardiologists and two hepatologists will interview and examine the enrolled patients and review the clinical records, laboratory and imaging findings to adjudicate the correct final cause of the ascites. They will have access to all
A Prospective Evaluation of Computerized Tomographic(CT) Scanning as a Screening Modality for Esophageal Varices
Nur registrierte Benutzer können Artikel übersetzen
Einloggen Anmelden
Study Group -We screened a population of 581 consecutive patients with cirrhosis who were scheduled to undergo upper gastrointestinal endoscopy. Exclusion criteria included inability to provide consent, patients who had previously undergone liver transplantation, previous portosystemic shunt
Acute Hemodynamics of Albumin Versus Normal Saline in Cirrhosis
Nur registrierte Benutzer können Artikel übersetzen
Einloggen Anmelden
Transjugular Intrahepatic Portosystemic Shunt With 8- or 10-mm Covered Stents
Nur registrierte Benutzer können Artikel übersetzen
Einloggen Anmelden
Clinical Efficacy of Transjugular Intrahepatic Portosystemic Shunt With 8- or 10-mm Covered Stents in Cirrhotic Patients:
A Randomized Controlled Study
Introduction In the treatment of esophageal varices rebleeding1 and ascites/hydrothorax refractory to the diuretic therapy2 by transjugular
Phase Ⅲ Randomized Trial in Postoperative Hepatocellular Carcinoma
Nur registrierte Benutzer können Artikel übersetzen
Einloggen Anmelden
1. TREATMENT PLAN
1.1 Eligible patients are randomized to receive adjuvant IFN-α for 53 wks or 1.2 Administration of IFN-α 1.21 IFN-α will be started after randomization. 1.22 IFN-α will be administered by subcutaneous injection at the bed time. 1.23 Escalation of IFN-α dosage. 1.231 During the
Die vollständigste Datenbank für Heilkräuter, die von der Wissenschaft unterstützt wird
- Arbeitet in 55 Sprachen
- Von der Wissenschaft unterstützte Kräuterkuren
- Kräutererkennung durch Bild
- Interaktive GPS-Karte - Kräuter vor Ort markieren (in Kürze)
- Lesen Sie wissenschaftliche Veröffentlichungen zu Ihrer Suche
- Suchen Sie nach Heilkräutern nach ihrer Wirkung
- Organisieren Sie Ihre Interessen und bleiben Sie über Neuigkeiten, klinische Studien und Patente auf dem Laufenden
Geben Sie ein Symptom oder eine Krankheit ein und lesen Sie über Kräuter, die helfen könnten, geben Sie ein Kraut ein und sehen Sie Krankheiten und Symptome, gegen die es angewendet wird.
* Alle Informationen basieren auf veröffentlichten wissenschaftlichen Forschungsergebnissen
